Thomas Hoover
Corporate Officer/Principal bij MATINAS BIOPHARMA HOLDINGS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Thomas J.
Hoover is currently the Chief Business Officer at Matinas BioPharma Holdings, Inc. Prior to this, he worked as the VP-New Product Planning & Corporate Development at Sumitomo Pharma America, Inc. from 2016 to 2021.
He also held the position of Senior Vice President-Commercial Strategy at Millendo Therapeutics, Inc. from 2016 to 2020.
Hoover has an MBA from Kenan-Flagler Business School and an undergraduate degree from Harvard College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Thomas Hoover
| Bedrijven | Functie | Begin |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Corporate Officer/Principal | 06-12-2021 |
Eerdere bekende functies van Thomas Hoover
| Bedrijven | Functie | Einde |
|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01-01-2021 |
| MILLENDO THERAPEUTICS | Corporate Officer/Principal | - |
Opleiding van Thomas Hoover
| Harvard College | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |